|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0021079,
umls-concept:C0021080,
umls-concept:C0035015,
umls-concept:C0194073,
umls-concept:C0205099,
umls-concept:C0205171,
umls-concept:C0205174,
umls-concept:C0442711,
umls-concept:C0450127,
umls-concept:C0596545,
umls-concept:C0676831,
umls-concept:C1548437,
umls-concept:C1882923
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-4-12
|
|
pubmed:abstractText |
Theoretically, an early protocol biopsy (PB) serves to detect subclinical rejection (SCR), allowing early treatment and prevention of acute rejection (AR) and chronic graft injuries. In this retrospective study, we investigated the incidence of biopsy-proven AR (BPAR) and the usefulness of a 3-month PB in detecting SCR in kidney transplant (KT) and simultaneous pancreas-kidney transplant (SPKT) recipients who received triple immunosuppression and basiliximab.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1437-7799
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
264-8
|
|
pubmed:meshHeading |
pubmed-meshheading:21170758-Adult,
pubmed-meshheading:21170758-Antibodies, Monoclonal,
pubmed-meshheading:21170758-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:21170758-Biopsy,
pubmed-meshheading:21170758-Cyclosporine,
pubmed-meshheading:21170758-Female,
pubmed-meshheading:21170758-Graft Rejection,
pubmed-meshheading:21170758-Humans,
pubmed-meshheading:21170758-Immunosuppression,
pubmed-meshheading:21170758-Immunosuppressive Agents,
pubmed-meshheading:21170758-Kidney Transplantation,
pubmed-meshheading:21170758-Male,
pubmed-meshheading:21170758-Middle Aged,
pubmed-meshheading:21170758-Pancreas Transplantation,
pubmed-meshheading:21170758-Recombinant Fusion Proteins,
pubmed-meshheading:21170758-Retrospective Studies,
pubmed-meshheading:21170758-Tacrolimus
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Usefulness of 3-month protocol biopsy of kidney allograft to detect subclinical rejection under triple immunosuppression with basiliximab: a single center experience.
|
|
pubmed:affiliation |
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
|
|
pubmed:publicationType |
Journal Article
|
